Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
ERIC RISBERG/AP
Gilead Sciences allegedly conspired with other drug makers whose medicines were part of a combination cocktail in order to block generic competition.
.png)
No hay comentarios:
Publicar un comentario